BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 6645932)

  • 1. [Results of a clinical multicenter study with Mono Mack 20 mg/40 mg].
    Schmidt G; Keller H; Jobst E
    Med Welt; 1983 Nov; 34(46):1322-4. PubMed ID: 6645932
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
    Uberbacher HJ; Glocke M; Abshagen U
    MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the therapeutic efficacy of slow-release isosorbide-5-mononitrate in ischemic cardiopathy].
    Schiavoni G; Bosimini E; Amico C
    Cardiologia; 1987 Nov; 32(11):1293-6. PubMed ID: 3447702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
    Kayali A
    Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mononitrates in long-term prophylaxis of angina pectoris: results of the first isosorbid-5-mononitrate symposium in Mannheim].
    Fortschr Med; 1981 Feb; 99(6):200-2. PubMed ID: 7024071
    [No Abstract]   [Full Text] [Related]  

  • 6. [The prophylactic effect of a combination of pindolol and isosorbide dinitrate on angina pectoris induced by arterial stimulation (author's transl)].
    Gavrilescu S; Pantzer M
    Schweiz Rundsch Med Prax; 1977 Aug; 66(35):1121-6. PubMed ID: 335384
    [No Abstract]   [Full Text] [Related]  

  • 7. Nitrate tolerance.
    Parker JO
    Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting nitrates in the prophylaxis of angina pectoris.
    Weiler-Ravell D; Bassan MM
    Br Med J; 1979 Jul; 2(6183):210-1. PubMed ID: 466367
    [No Abstract]   [Full Text] [Related]  

  • 9. [Previous history and principles of the development of isosorbide-5-mononitrate (IS-5-MN)].
    Schaumann W
    Med Welt; 1981 Apr; 32(14A):479-80. PubMed ID: 7242305
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for prophylaxis of angina pectoris.
    Med Lett Drugs Ther; 1975 Jul; 17(14):57-8. PubMed ID: 805906
    [No Abstract]   [Full Text] [Related]  

  • 11. Isosorbide dinitrate in clinical practice.
    Swedberg K
    Scand J Clin Lab Invest Suppl; 1984; 173():85-91. PubMed ID: 6152077
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nitrate tolerance: pro and con].
    Silber S
    Dtsch Med Wochenschr; 1984 Jul; 109(28-29):1124-32. PubMed ID: 6430664
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isosorbide dinitrate tolerance in the treatment of patients with angina pectoris and the effect of addition of captopril on therapeutic results].
    Rotrekl P; Lupínek Z; Meluzín J; Novák M
    Vnitr Lek; 1991; 37(7-8):625-32. PubMed ID: 1755201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
    Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
    Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
    [No Abstract]   [Full Text] [Related]  

  • 16. [Continuous infusion of isosorbide dinitrate in intractable rest angina pectoris: report of a case].
    Fujii K; Tauchi M; Hoshida S; Kagiya T; Ozaki H; Mishima M; Kitabatake A; Inoue M; Kamata T
    J Cardiol Suppl; 1989; 22():17-9. PubMed ID: 2640861
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 18. [Iso Mack Retard 40 mg. Coronary drug for long term therapy and prophylaxis in coronary circulation disorders (angina pectoris)].
    Wien Klin Wochenschr; 1980 Oct; 92(19):695-6. PubMed ID: 7467343
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isosorbide dinitrate in exercise induced angina pectoris despite use of beta-blocking treatment. Clinical and hematological effects assessed by isotope angiocardiography].
    Jensen G; Trautner F; Rasmussen S; Hesse B
    Ugeskr Laeger; 1982 Nov; 144(44):3247-50. PubMed ID: 6761921
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
    Müller G; Uberbacher HJ; Glocke M
    Med Welt; 1983 Mar; 34(10):321-7. PubMed ID: 6133205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.